Sumant Lamba

3.9k total citations · 2 hit papers
23 papers, 1.9k citations indexed

About

Sumant Lamba is a scholar working on Cardiology and Cardiovascular Medicine, Emergency Medicine and Surgery. According to data from OpenAlex, Sumant Lamba has authored 23 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 4 papers in Emergency Medicine and 3 papers in Surgery. Recurrent topics in Sumant Lamba's work include Heart Failure Treatment and Management (17 papers), Cardiovascular Function and Risk Factors (8 papers) and Emergency and Acute Care Studies (4 papers). Sumant Lamba is often cited by papers focused on Heart Failure Treatment and Management (17 papers), Cardiovascular Function and Risk Factors (8 papers) and Emergency and Acute Care Studies (4 papers). Sumant Lamba collaborates with scholars based in United States, Norway and France. Sumant Lamba's co-authors include William T. Abraham, Alan B. Storrow, Arne Westheim, Peter A. McCullough, Judd E. Hollander, James McCord, Philippe Gabríel Steg, Alan S. Maisel, Richard M. Nowak and Alan H.B. Wu and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Sumant Lamba

22 papers receiving 1.8k citations

Hit Papers

B-Type Natriuretic Peptide and Clinical Judgment in Emerg... 2002 2026 2010 2018 2002 2021 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sumant Lamba United States 12 1.5k 519 283 236 217 23 1.9k
Cathrine Wold Knudsen Norway 16 2.0k 1.3× 560 1.1× 359 1.3× 323 1.4× 177 0.8× 22 2.4k
Haris Subačius United States 29 2.1k 1.4× 271 0.5× 322 1.1× 188 0.8× 129 0.6× 74 2.5k
Janet Wynne United States 13 2.0k 1.3× 516 1.0× 317 1.1× 192 0.8× 423 1.9× 16 2.4k
Mattia Arrigo Switzerland 22 1.2k 0.8× 318 0.6× 397 1.4× 168 0.7× 275 1.3× 75 1.7k
Vincent M. van Deursen Netherlands 13 1.2k 0.8× 412 0.8× 342 1.2× 284 1.2× 179 0.8× 22 1.7k
Lenka Špinarová Czechia 19 2.3k 1.5× 482 0.9× 374 1.3× 210 0.9× 209 1.0× 114 2.7k
Justin Vader United States 21 1.1k 0.7× 297 0.6× 462 1.6× 124 0.5× 400 1.8× 76 1.6k
Katsuya Kajimoto Japan 20 1.1k 0.8× 333 0.6× 251 0.9× 178 0.8× 98 0.5× 62 1.6k
Yuichiro Minami Japan 20 1.2k 0.8× 297 0.6× 259 0.9× 191 0.8× 91 0.4× 78 1.5k
M Huelsmann Austria 18 1.2k 0.8× 278 0.5× 265 0.9× 193 0.8× 153 0.7× 48 1.4k

Countries citing papers authored by Sumant Lamba

Since Specialization
Citations

This map shows the geographic impact of Sumant Lamba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumant Lamba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumant Lamba more than expected).

Fields of papers citing papers by Sumant Lamba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumant Lamba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumant Lamba. The network helps show where Sumant Lamba may publish in the future.

Co-authorship network of co-authors of Sumant Lamba

This figure shows the co-authorship network connecting the top 25 collaborators of Sumant Lamba. A scholar is included among the top collaborators of Sumant Lamba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumant Lamba. Sumant Lamba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lewis, Gregory D., Kensey Gosch, Laura Cohen, et al.. (2023). Effect of Dapagliflozin on 6-Minute Walk Distance in Heart Failure With Preserved Ejection Fraction: PRESERVED-HF. Circulation Heart Failure. 16(11). e010633–e010633. 7 indexed citations
2.
Kosiborod, Mikhail, Michael E. Nassif, Sheryl L. Windsor, et al.. (2019). Effects of Dapagliflozin on Biomarkers, Symptoms and Functional Status in Patients with Heart Failure with Reduced Ejection Fraction with and without Diabetes - The Define-HF Trial. Journal of Cardiac Failure. 25(11). 937–938. 2 indexed citations
3.
Heywood, J. Thomas, Rita Jermyn, David M. Shavelle, et al.. (2017). Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted With the CardioMEMS Sensor. Circulation. 135(16). 1509–1517. 108 indexed citations
4.
Iyengar, Srinivas, Garrie J. Haas, Sumant Lamba, et al.. (2007). Effect of Cardiac Resynchronization Therapy on Myocardial Gene Expression in Patients with Nonischemic Dilated Cardiomyopathy. Journal of Cardiac Failure. 13(4). 304–311. 36 indexed citations
5.
McCord, James, Richard M. Nowak, Gordon Jacobsen, et al.. (2005). B-Type Natriuretic Peptide Levels in Patients in the Emergency Department With Possible Heart Failure and Previous Stable Angina Pectoris and/or Healed Myocardial Infarction. The American Journal of Cardiology. 96(10). 1370–1373. 2 indexed citations
6.
Trupp, Robin J., et al.. (2004). Prevalence of Sleep Disordered Breathing in a Heart Failure Program. Congestive Heart Failure. 10(5). 217–220. 15 indexed citations
7.
McCullough, Peter A., Judd E. Hollander, Richard M. Nowak, et al.. (2003). Uncovering Heart Failure in Patients with a History of Pulmonary Disease: Rationale for the Early Use of B‐type Natriuretic Peptide in the Emergency Department. Academic Emergency Medicine. 10(3). 198–204. 79 indexed citations
8.
McCullough, Peter A., Philippe Gabríel Steg, Marie-Claude Aumont, et al.. (2003). What causes elevated B-type natriuretic peptide in patients without heart failure?. Journal of the American College of Cardiology. 41(6). 278–279. 9 indexed citations
9.
McCullough, Peter A., Philippe Duc, Torbjørn Omland, et al.. (2003). B-type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the BNP multinational study. Journal of the American College of Cardiology. 41(6). 222–222. 1 indexed citations
10.
McCullough, Peter A., Judd E. Hollander, Richard M. Nowak, et al.. (2003). Uncovering Heart Failure in Patients with a History of Pulmonary Disease: Rationale for the Early Use of B-type Natriuretic Peptide in the Emergency Department. Academic Emergency Medicine. 10(3). 198–204. 154 indexed citations
11.
McCullough, Peter A., Richard M. Nowak, James McCord, et al.. (2003). What is in the differential diagnosis of a B-type natriuretic peptide level of 1,000 pg/ml?. Journal of the American College of Cardiology. 41(6). 159–159. 31 indexed citations
12.
Baas, Linda S., Theresa A. Beery, Gordon A. Allen, et al.. (2003). Accuracy of the precordial V-Quick® patch in persons with cardiac or pulmonary disease. Journal of Emergency Medicine. 24(2). 131–139. 2 indexed citations
13.
McCullough, Peter A., Torbjørn Omland, Catherine W. Knudsen, et al.. (2003). Uncovering heart failure in patients with bronchospasm: Rationale for the early use of B-type natriuretic peptide in the emergency department. Journal of the American College of Cardiology. 41(6). 142–143.
14.
Trupp, Robin J., William T. Abraham, & Sumant Lamba. (2003). Future therapies for heart failure. Critical Care Nursing Clinics of North America. 15(4). 525–530. 1 indexed citations
15.
Jaski, Brian E., et al.. (2003). Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. Journal of Cardiac Failure. 9(3). 227–231. 117 indexed citations
16.
McCullough, Peter A., Philippe Duc, Torbjørn Omland, et al.. (2003). B-type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the breathing not properly multinational study. American Journal of Kidney Diseases. 41(3). 571–579. 396 indexed citations
17.
Maisel, Alan S., Radmila Kazanegra, James McCord, et al.. (2002). Primary results of the BNP multinational study: B-type natriuretic peptide in the emergency diagnosis of heart failure. Journal of the American College of Cardiology. 39. 201–201. 1 indexed citations
18.
McCullough, Peter A., Richard M. Nowak, James McCord, et al.. (2002). B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure. Circulation. 106(4). 416–422. 658 indexed citations breakdown →
19.
Lamba, Sumant & William T. Abraham. (2000). Alterations in Adrenergic Receptor Signaling in Heart Failure. Heart Failure Reviews. 5(1). 7–16. 35 indexed citations
20.
Suresh, Damodhar P., Sumant Lamba, & William T. Abraham. (2000). New developments in heart failure: Role of endothelin and the use of endothelin receptor antagonists. Journal of Cardiac Failure. 6(4). 359–368. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026